| dc.contributor.author |
Horner, Stacy M |
|
| dc.contributor.author |
Naggie, Susanna |
|
| dc.coverage.spatial |
United States |
|
| dc.date.accessioned |
2015-09-05T18:24:01Z |
|
| dc.date.issued |
2015-06 |
|
| dc.identifier |
http://www.ncbi.nlm.nih.gov/pubmed/26087286 |
|
| dc.identifier |
PPATHOGENS-D-15-00053 |
|
| dc.identifier.uri |
https://hdl.handle.net/10161/10588 |
|
| dc.language |
eng |
|
| dc.publisher |
Public Library of Science (PLoS) |
|
| dc.relation.ispartof |
PLoS Pathog |
|
| dc.relation.isversionof |
10.1371/journal.ppat.1004854 |
|
| dc.subject |
Antiviral Agents |
|
| dc.subject |
Hepatitis C |
|
| dc.subject |
Humans |
|
| dc.title |
Successes and Challenges on the Road to Cure Hepatitis C. |
|
| dc.type |
Journal article |
|
| duke.contributor.id |
Horner, Stacy M|0630632 |
|
| duke.contributor.id |
Naggie, Susanna|0290208 |
|
| pubs.author-url |
http://www.ncbi.nlm.nih.gov/pubmed/26087286 |
|
| pubs.begin-page |
e1004854 |
|
| pubs.issue |
6 |
|
| pubs.organisational-group |
Basic Science Departments |
|
| pubs.organisational-group |
Clinical Science Departments |
|
| pubs.organisational-group |
Duke |
|
| pubs.organisational-group |
Duke Cancer Institute |
|
| pubs.organisational-group |
Duke Clinical Research Institute |
|
| pubs.organisational-group |
Institutes and Centers |
|
| pubs.organisational-group |
Medicine |
|
| pubs.organisational-group |
Medicine, Infectious Diseases |
|
| pubs.organisational-group |
Molecular Genetics and Microbiology |
|
| pubs.organisational-group |
School of Medicine |
|
| pubs.publication-status |
Published online |
|
| pubs.volume |
11 |
|
| dc.identifier.eissn |
1553-7374 |
|
| duke.contributor.orcid |
Horner, Stacy M|0000-0002-9351-7409 |
|
| duke.contributor.orcid |
Naggie, Susanna|0000-0001-7721-6975 |
|
